A comparison of fulvestrant plus a targeted agent with fulvestrant alone in hormone receptor-positive advanced breast cancer that progressed on prior endocrine therapy: a meta-analysis

Xu L, Yan N, Li Z, Luo L, Wu X, Liu Q, Xu Y, Cao Y

OncoTargets and Therapy 2018, 11:8389-8398

Published Date: 27 November 2018